Price Alert

CONMED Corporation (CNMD)

NYSE: CNMD · Real-Time Price · USD

53.31

0.67 (1.27%)

At close: Aug 15, 2025, 9:54 AM

CONMED Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	342.35M	321.26M	347.93M	316.7M	330.75M	311.63M	327.05M	304.58M	317.65M	295.47M	250.87M	275.09M	277.19M	242.33M	273.97M	248.83M	255.16M	232.68M
Cost of Revenue	154.03M	143.5M	147.6M	137.71M	157.59M	149.65M	142.72M	136.52M	146.96M	140.15M	119M	123.47M	125.41M	106.34M	118.11M	106.52M	113.74M	104.23M
Gross Profit	188.32M	177.75M	200.33M	179M	173.15M	161.98M	184.33M	168.06M	170.69M	155.32M	131.86M	151.62M	151.78M	135.99M	155.86M	142.31M	141.42M	128.45M
Operating Income	38.16M	15.96M	52.5M	65.71M	37.21M	42.29M	42.97M	30.3M	27.42M	-5.24M	-1.09M	6.62M	24.46M	5.61M	37.22M	26.71M	25.71M	20.08M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	29.92M	7.67M	43.64M	56.45M	37.51M	25.42M	40.68M	20.28M	17.42M	2.44M	-10.54M	15.71M	-93.48M	17.45M	29.65M	17.44M	16.29M	9.73M
Net Income	21.42M	6.04M	33.76M	48.98M	29.98M	19.71M	33.07M	15.84M	13.73M	1.82M	26.58M	46.15M	-168.29M	14.97M	24.44M	14.95M	13.29M	9.86M
Selling & General & Admin	136.02M	144.85M	132.67M	99.73M	121.84M	106.1M	127.33M	125.3M	129.7M	130.08M	120.74M	114.6M	115.83M	102.88M	107.28M	104.74M	104.4M	98.34M
Research & Development	14.14M	12.95M	13.18M	13.56M	14.1M	13.59M	14.03M	12.46M	13.57M	12.54M	12.22M	12.77M	11.49M	10.67M	11.36M	10.86M	11.32M	10.03M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.13M	n/a	n/a
Operating Expenses	150.16M	161.79M	145.84M	113.29M	135.94M	119.69M	141.36M	137.76M	143.27M	142.62M	132.96M	127.37M	127.32M	113.55M	118.64M	115.59M	115.72M	108.37M
Interest Expense	7.82M	8.29M	8.86M	9.25M	9.59M	9.59M	9.51M	10.02M	10M	10.26M	9.44M	8.54M	5.93M	5M	7.57M	8.14M	9.42M	10.35M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	304.18M	305.3M	293.44M	250.99M	293.54M	269.35M	284.07M	274.28M	290.23M	282.77M	251.96M	250.84M	252.73M	219.88M	236.75M	222.12M	229.45M	212.59M
Income Tax Expense	8.5M	1.64M	9.89M	7.47M	7.54M	5.71M	7.61M	4.44M	3.69M	625K	-37.12M	-30.44M	74.81M	2.47M	5.2M	2.49M	3M	-129K
Shares Outstanding (Basic)	30.95M	30.97M	30.85M	30.86M	30.81M	30.78M	30.76M	30.74M	30.66M	30.51M	30.48M	30.47M	29.77M	35.16M	29.35M	29.18M	29.13M	28.97M
Shares Outstanding (Diluted)	31.05M	31.15M	31.11M	31.11M	31.11M	31.27M	31.5M	31.69M	31.8M	31.2M	30.93M	31.1M	29.77M	35.16M	32.77M	32.14M	32.46M	31.38M
EPS (Basic)	0.69	0.19	1.09	1.59	0.97	0.64	1.08	0.52	0.45	0.06	0.87	1.51	-5.65	0.43	0.83	0.51	0.46	0.34
EPS (Diluted)	0.69	0.19	1.08	1.57	0.96	0.63	1.05	0.50	0.43	0.06	0.86	1.48	-5.65	0.43	0.75	0.47	0.41	0.31
EBITDA	38.16M	34.21M	70.5M	83.68M	47.11M	54.93M	60.97M	30.3M	27.42M	12.7M	16.64M	24.25M	-75.3M	22.44M	54.69M	37.66M	25.71M	38.36M
EBIT	37.74M	15.96M	52.5M	65.71M	47.11M	35.01M	50.19M	30.3M	27.42M	12.7M	-1.09M	24.25M	-87.55M	22.44M	37.22M	25.58M	25.71M	20.08M
Depreciation & Amortization	n/a	18.25M	18.01M	17.97M	12.77M	12.65M	18M	12.63M	12.96M	12.86M	17.73M	12.64M	12.26M	12.03M	17.48M	12.08M	12.18M	18.28M